Perinatal Trials Unit Foundation Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 5 Year, 5 Months
- Last Filing with ROC 31 Mar 2022
About Perinatal Trials Unit Foundation
Perinatal Trials Unit Foundation (PTUF) is a Private Not For Profit Company incorporated in India on 13 August 2019 (Five years and five months 23 days old ). Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Research & Development Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Ravi Swamy and Rekha Swamy serve as directors at the Company.
Company Details
-
Location
Bangaluru, Karnataka, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U73100KA2019NPL127020
-
Company No.
127020
-
Company Classification
Private Not For Profit Company
-
Incorporation Date
13 Aug 2019
-
Date of AGM
30 Sep 2022
-
Date of Balance Sheet
31 Mar 2022
-
Listing Status
Unlisted
-
ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Perinatal Trials Unit Foundation?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ravi Swamy
|
Director | 13-Aug-2019 | Current |
|
Rekha Swamy
|
Director | 13-Aug-2019 | Current |
Financial Performance of Perinatal Trials Unit Foundation.
Perinatal Trials Unit Foundation, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Perinatal Trials Unit Foundation?
Unlock access to Perinatal Trials Unit Foundation's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Reprosci Biosciences Private LimitedRavi Swamy is a mutual person
-
R & R Family Health Services LlpRavi Swamy is a mutual person
-
Peopletech Healthcare Llp
Ravi Swamy and Rekha Swamy are mutual person
-
Reviverays Healthcare Technologies Private Limited
Ravi Swamy and Rekha Swamy are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Perinatal Trials Unit Foundation?
Unlock and access historical data on people associated with Perinatal Trials Unit Foundation, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Perinatal Trials Unit Foundation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Perinatal Trials Unit Foundation's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.